Idexx Laboratories (IDXX) Cash from Operations (2009 - 2026)

Idexx Laboratories' Cash from Operations history runs 18 years deep, the most recent figure standing at 266248000.0 for Q1 2026.

• In Q1 2026, Cash from Operations rose 11.89% year-over-year to 266248000.0; the TTM figure through Mar 2026 stood at 1210091000.0 (up 24.96% YoY), while the FY2025 annual figure was 1181805000.0, up 27.21% from the prior year.
• Cash from Operations for Q1 2026 stood at 266248000.0, down from 355760000.0 in the prior quarter.
• The five-year high for Cash from Operations was 402340000.0 in Q3 2025, with the low at 65850000.0 in Q2 2022.
• The 5-year median for Cash from Operations is 220079000.0 (2024), against an average of 225091058.82.
• The sharpest annual moves came in 2022 and 2023: Cash from Operations plunged 71.85% in 2022, then jumped 204.2% in 2023.
• Idexx Laboratories' Cash from Operations stood at 173428000.0 in 2022, then soared by 44.07% to 249851000.0 in 2023, then rose by 4.87% to 262025000.0 in 2024, then surged by 35.77% to 355760000.0 in 2025, then dropped by 25.16% to 266248000.0 in 2026.
• Business Quant data shows IDXX's Cash from Operations at 266248000.0 in Q1 2026, 355760000.0 in Q4 2025, and 402340000.0 in Q3 2025.